ScholarIQanswers from OpenAlex

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection

PaperCitations, authors & open-access status

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection have?

ScholarIQcitation count

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection has 304 citations in the OpenAlex counts ScholarIQ stores.

When was Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection published?

ScholarIQyear

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection has 2021 year in the ScholarIQ index.

What is the open-access status of Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection?

ScholarIQoa status

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection has closed oa status in the ScholarIQ index.

What is the DOI of Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection?

ScholarIQdoi

The DOI for Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection is on the source record.

What is the PMID of Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection?

ScholarIQpmid

The PMID for Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection is on the source record.

What is the OpenAlex record for Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection?

ScholarIQopenalex

The OpenAlex for Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial